Verve Therapeutics
Price & Volume
Stats
See more52W Range | $4.30-$19.34 |
Market Cap | $409.7M |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $24.3M |
Revenue Growth (YoY) | 120.2% |
Gross Profit (12 Mos) | -$128.1M |
Diluted EPS | -$2.46 |
News
See moreYahoo Finance • 2 months ago
Is Verve Therapeutics, Inc. (VERV) the Best NASDAQ Stock Under $5?
Yahoo Finance • 2 months ago
Jim Cramer on Verve Therapeutics Inc. (VERV): ‘I Think It’s A Winner’
Yahoo Finance • 11 months ago
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics
Yahoo Finance • 11 months ago
12 Best Genomics Stocks To Buy Now
About
CEO | Dr. Sekar Kathiresan M.D. |
Address | 201 Brookline Avenue, Cambridge, MA, United States, 02215 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 255 |
